The Global Rett Syndrome Market is navigating a historic era of medical discovery. For decades, treatment was limited to palliative care, but with the 2023 FDA approval of the first disease-modifying therapy and a surge in gene-editing research, the market is expanding at an astronomical rate. https://livepositively.com/unlocking-value-pricing-regulatory-landscape-and-future-forecast-for-the-ocular-bromfenac-market-2025-2032/